0001062993-19-002783.txt : 20190702
0001062993-19-002783.hdr.sgml : 20190702
20190702144813
ACCESSION NUMBER: 0001062993-19-002783
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190701
FILED AS OF DATE: 20190702
DATE AS OF CHANGE: 20190702
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Schamroth Michael
CENTRAL INDEX KEY: 0001375385
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-34236
FILM NUMBER: 19936736
MAIL ADDRESS:
STREET 1: 191 MEADOWVIEW AVENUE
CITY: HEWLETT
STATE: NY
ZIP: 11557
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: BIOSPECIFICS TECHNOLOGIES CORP
CENTRAL INDEX KEY: 0000875622
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 113054851
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 35 WILBUR ST
CITY: LYNBROOK
STATE: NY
ZIP: 11563
BUSINESS PHONE: 5165937000
MAIL ADDRESS:
STREET 1: 35 WILBUR STREET
CITY: LYNBROOK
STATE: NY
ZIP: 11563
4
1
form4.xml
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
X0306
4
2019-07-01
0000875622
BIOSPECIFICS TECHNOLOGIES CORP
BSTC
0001375385
Schamroth Michael
C/O BIOSPECIFICS TECHNOLOGIES CORP. 35 W
LYNBROOK
NY
11563
1
0
0
0
Common Stock, $0.001 par value
2019-07-01
4
A
0
1890
0
A
100890
D
Grant of restricted stock units under the BioSpecifics Technologies Corp. 2019 Omnibus Incentive Compensation Plan.
/s/ Michael Schamroth by Carl A. Valenstein, attorney- in-fact
2019-07-02